tm logo
ILUVIEN
Live/Registered
REGISTERED AND RENEWED

on 02 Dec 2021

Last Applicant/ Owned by

6310 Town Square, Suite 400

Alpharetta

GA

30005

Serial Number

77162736 filed on 23rd Apr 2007

Registration Number

4045625 registered on 25th Oct 2011

in the Principal Register

Correspondent Address

Kevin W. King

Kevin W. King

999 Peachtree Street NE

Atlanta GA 30309-3996

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

ILUVIEN

Sustained drug delivery systems for ocular drugs Drug delivery agents consisting of polymer compounds that facilitate the delivery of pharmaceuticals for the treatment of macular edema, macular disease, retinal disease, glaucoma, and occular allergy

Classification Information


Class [005]
Pharmaceutical Products


Drug delivery agents consisting of polymer compounds that facilitate the delivery of pharmaceuticals for the treatment of macular edema, macular disease, retinal disease, glaucoma, and occular allergy


First Use Date in General

31st Jul 2008

First Use Date in Commerce

31st Aug 2008

Class [010]
Medical Instrument Products


Sustained drug delivery systems for ocular drugs


First Use Date in General

31st Aug 2008

First Use Date in Commerce

30th Sep 2008

Mark Details


Serial Number

No 77162736

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 35962-0032

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
05th Apr 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
25th Jan 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
25th Jan 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
25th Jan 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
25th Jan 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
25th Jan 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
02th Dec 2021REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
02th Dec 2021REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
02th Dec 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
19th Nov 2021TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED